BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25529476)

  • 1. Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.
    Holmgren G; Synnergren J; Bogestål Y; Améen C; Åkesson K; Holmgren S; Lindahl A; Sartipy P
    Toxicology; 2015 Feb; 328():102-11. PubMed ID: 25529476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology.
    Zhang L; Xu MX; Yin QS; Zhu CY; Cheng XL; Ren YR; Zhuang PW; Zhang YJ
    Toxicol Lett; 2017 Feb; 268():17-25. PubMed ID: 28099878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.
    Chaudhari U; Nemade H; Gaspar JA; Hescheler J; Hengstler JG; Sachinidis A
    Arch Toxicol; 2016 Dec; 90(12):3087-3098. PubMed ID: 26842497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression Profiling of Human Pluripotent Stem Cell-Derived Cardiomyocytes Exposed to Doxorubicin-Integration and Visualization of Multi-Omics Data.
    Holmgren G; Sartipy P; Andersson CX; Lindahl A; Synnergren J
    Toxicol Sci; 2018 May; 163(1):182-195. PubMed ID: 29385562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.
    Chaudhari U; Nemade H; Wagh V; Gaspar JA; Ellis JK; Srinivasan SP; Spitkovski D; Nguemo F; Louisse J; Bremer S; Hescheler J; Keun HC; Hengstler JG; Sachinidis A
    Arch Toxicol; 2016 Nov; 90(11):2763-2777. PubMed ID: 26537877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
    Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity.
    Holmgren G; Synnergren J; Andersson CX; Lindahl A; Sartipy P
    Toxicol In Vitro; 2016 Aug; 34():26-34. PubMed ID: 27033315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells.
    Andersson H; Steel D; Asp J; Dahlenborg K; Jonsson M; Jeppsson A; Lindahl A; Kågedal B; Sartipy P; Mandenius CF
    J Biotechnol; 2010 Oct; 150(1):175-81. PubMed ID: 20633583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
    Ting S; Chen A; Reuveny S; Oh S
    Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes.
    Karhu ST; Kinnunen SM; Tölli M; Välimäki MJ; Szabó Z; Talman V; Ruskoaho H
    Arch Toxicol; 2020 Jun; 94(6):2113-2130. PubMed ID: 32185414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes.
    Louisse J; Wüst RCI; Pistollato F; Palosaari T; Barilari M; Macko P; Bremer S; Prieto P
    Toxicol In Vitro; 2017 Aug; 42():182-190. PubMed ID: 28456566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Chaudhari U; Ellis JK; Wagh V; Nemade H; Hescheler J; Keun HC; Sachinidis A
    Amino Acids; 2017 Dec; 49(12):1955-1963. PubMed ID: 28421296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulatory mechanisms of myogenin expression in doxorubicin-treated rat cardiomyocytes.
    Liu ST; Huang SM; Ho CL; Yen LC; Huang CJ; Lin WS; Chan JY
    Oncotarget; 2015 Nov; 6(35):37443-57. PubMed ID: 26452256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression and pharmaceutical efficacy of cardiac-specific ion channels in human embryonic stem cell-derived cardiomyocytes.
    Kim HS; Yoon JW; Li H; Jeong GO; Park JJ; Shin SE; Jang IH; Kim JH; Park WS
    Sci Rep; 2017 Oct; 7(1):13821. PubMed ID: 29062050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse embryonic stem cells irradiated with γ-rays differentiate into cardiomyocytes but with altered contractile properties.
    Rebuzzini P; Fassina L; Mulas F; Bellazzi R; Redi CA; Di Liberto R; Magenes G; Adjaye J; Zuccotti M; Garagna S
    Mutat Res; 2013 Aug; 756(1-2):37-45. PubMed ID: 23792212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide induced early gene expression perturbations indicative of human embryopathy in mouse embryonic stem cells.
    Gao X; Sprando RL; Yourick JJ
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):43-51. PubMed ID: 26006729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Troponins are Among Targets of Doxorubicin-Induced Cardiotoxicity in hiPCS-CMs.
    Adamcova M; Skarkova V; Seifertova J; Rudolf E
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.